Tissue Factor as an Effector of Angiogenesis and Tumor Progression in Hematological Malignancies

Leukemia - United Kingdom
doi 10.1038/sj.leu.2404264
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Is Angiogenesis Essential for the Progression of Hematological Malignancies or Is It an Epiphenomenon?

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Tissue Factor (TF) Expression and Angiogenesis in Tumor Progression and Inhibition of Tumor Growth by Anti-Tf Antibodies in Human Tissue Factor Knock-In Mice

Journal of Carcinogenesis & Mutagenesis
2012English

T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies

Frontiers in Immunology
AllergyImmunology
2020English

Profilin Phosphorylation as a VEGFR Effector in Angiogenesis

Nature Cell Biology
Cell Biology
2012English

Telomerase Activation in Hematological Malignancies

Genes
Genetics
2016English

Tissue Factor Expression, Angiogenesis, and Thrombosis in Pancreatic Cancer

Clinical Cancer Research
Cancer ResearchOncology
2007English

Bridging the Gap in Hematological Malignancies

Expert Review of Hematology
Hematology
2012English

Clinical, Hematological and Cytogenetic Profile in Fibroblast Growth Factor Receptor 1 Rearranged Hematoloymphoid Malignancies

International Journal of Research in Medical Sciences
2020English

I(5)(p10) in Hematological Malignancies

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy